期刊文献+

低水平万古霉素耐药金黄色葡萄球菌的研究进展 被引量:9

Research progress in Staphylococcus aureus with reduced vancomyein susceptibility
原文传递
导出
摘要 近年来,万古霉素耐药的金黄色葡萄球菌不断增多,给临床抗感染治疗带来新的难题,正确认识万古霉素耐药的金黄色葡萄球菌对于临床医生及感染控制人员非常重要。本文对低水平万古霉素耐药金黄色葡萄球菌的流行病学、检测、耐药机制及治疗方面做简要综述。 In recent years,vancomycin resistant Staphycoloccus aureus has been increasing, which has brought a new challenge to anti-infective theraphy in clinic. It is very important for clinician and infection controlmen to have a correct understanding of vancomycin resistant Staphylococcus aureus. This article mainly reviews the epidemiology, detection, drug resistant mechanism and treatment of Staphylococcus aureus with reduced vancomycin susceptibility.
出处 《国际呼吸杂志》 2010年第4期247-250,共4页 International Journal of Respiration
关键词 万古霉素中介金黄色葡萄球菌 异质性万古霉素中介金黄色葡萄球菌 万古霉素 最低抑菌浓度 Vancomycin intermediate Staphylococcus aureus Heterogeneous vancomycin intermediate Staphylococcus aureus Vancomycin Minimal inhibitory concentration
  • 相关文献

参考文献20

  • 1马筱玲.万古霉素敏感性减低的金黄色葡萄球菌[J].浙江检验医学,2008,0(1):16-18. 被引量:1
  • 2Hiramatsu K,Aritaka N,Hanaki H,et al.Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.Lancet,1 997,350:1670-1673.
  • 3Finks J,Wells E,Dyke TL,et al.Vancomycin-resistant Staphylococcus auFeus,Michigan,USA,2007.Emerg Infect Dis,2009,15:943-945.
  • 4马筱玲,王敬华,李华,陈多炎,濮跃晨.异质性万古霉素耐药葡萄球菌分离及生物学特性观察[J].中华微生物学和免疫学杂志,2004,24(7):583-586. 被引量:48
  • 5Hiramatsu K.Vancomycin-resistant Staphylococcus aureus:a new model of antibiotic resistance.Lancet Infect Dis,2001,1:147-155.
  • 6Lodise TP,Miller CD,Graves J,et al.Predictors of high vancomycin MIC values among patients with methicillinresistant Staphylococcus aureus bacteraemia.J Antimicrob Chemother,2008,62:1138-1141.
  • 7Charles PG,Ward PB,Johnson PD,et al.Clinical features associated with bacteremia due to heterogeneous vancomycinintermediate Staphylococcus aureus.Clin Infect Dis,2004,38:448-451.
  • 8wootton M,MacGowan AP,Walsh TR.et al.A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides.J Clin Microbiol,2007,45:329-332.
  • 9Liu C,Chambers HF,Staphylococcus aureus with heterogeneous resistance to vancomycm:epidemlology,clinical significance,and critical assessment of diagnostic methods.Antimicrob Agents Chemother,2003,47:3040-3045.
  • 10Leonard SN,Rossi KL,Newton KL,et al.Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glyeopeptides.J Antimicrob Chemother,2009,63:489-492.

二级参考文献34

  • 1CDC. Staphylococcus aureus resistant to Vancomycin-United States,2002. Morb Mortal Wkly Rep, 2002, 51(26): 565-567.
  • 2CDC. Public Health Dispatch: Vancoomycin-Resistant Staphylococcus aureusPennsylvania, 2002. Morb Mortal Wkly Rep, 2, 2002, 51(40): 902.
  • 3Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother, 1997, 40(1): 135-136.
  • 4Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet, 1997, 350(12): 1670-1673.
  • 5Sieradzki K, Villari P, Tomasz A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of Staphylococci. Antimicrob Agents Chemother, 1998, 42(1):100-107.
  • 6Marchese A, Balistreri G, Tonoli E, et al. Heterogeneous vancomycin resistance in mehthiillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital . J Clin Microbiol, 2000, 38(2): 866-869.
  • 7Poly MC, Grelaud C, Martin C, et al. First clinical isolate of vancomycin-intermediate Stsaphylococcus in a French hospital. Lancet, 1998,351: 1212.
  • 8Viedma DG, Rabadan PM, Diaz M, et al. Heterogeneous antimicrobial resistance patterns in polyclonal populations of coagulase-negative Staphylococcus isolated from catheters. J Clin Microbiol, 2000, 38(4): 1359-1363.
  • 9Wong SSY, Ho PL, Woo PCY, et al. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis, 1999,29: 760-767.
  • 10CDC. Investigation and Control of Vancomycin-Intermediate and resistant Staphylococcus aureus: A guide for health department and infection control personnel. Atlanta, GA. 2003 (Accessed at http://www. cdc.gov/ncidod/hip/ARESIST/visa-vrsa-guide. pdf)

共引文献47

同被引文献86

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部